These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36320653)

  • 1. Endocrine hormone imbalance in heart failure with reduced ejection fraction: A cross-sectional study.
    Nägele MP; Barthelmes J; Kreysing L; Haider T; Nebunu D; Ruschitzka F; Sudano I; Flammer AJ
    Health Sci Rep; 2022 Nov; 5(6):e880. PubMed ID: 36320653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Pathophysiologic Insights of Free triiodothyronine/Free thyroxine Ratio in Patients with Heart Failure with Preserved Ejection Fraction: Data from the NETDiamond Cohort.
    Leite AR; Neves JS; Angélico-Gonçalves A; Vasques-Nóvoa F; Saraiva FA; Pinho IB; Oliveira AC; Borges-Canha M; von Hafe M; Vale C; Lourenço AP; Macedo F; Araújo JP; von Hafe P; Almeida J; Ferreira JP; Leite-Moreira A
    Cardiology; 2023; 148(3):239-245. PubMed ID: 37285810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selenium deficiency and the dynamics of changes of thyroid profile in patients with acute myocardial infarction and chronic heart failure.
    Frączek-Jucha M; Kabat M; Szlósarczyk B; Czubek U; Nessler J; Gackowski A
    Kardiol Pol; 2019 Aug; 77(7-8):674-682. PubMed ID: 31066725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of sex-related and thyroid-related hormones with risk of metabolic dysfunction-associated fatty liver disease in T2DM patients.
    Lu W; Li S; Li Y; Zhou J; Wang K; Chen N; Li Z
    BMC Endocr Disord; 2024 Jun; 24(1):84. PubMed ID: 38849804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.
    Chan MM; Santhanakrishnan R; Chong JP; Chen Z; Tai BC; Liew OW; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong RC; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2016 Jan; 18(1):81-8. PubMed ID: 26497848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory pathways in patients with heart failure and preserved ejection fraction.
    Niethammer M; Sieber M; von Haehling S; Anker SD; Munzel T; Horstick G; Genth-Zotz S
    Int J Cardiol; 2008 Sep; 129(1):111-7. PubMed ID: 17658631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world clinical diagnostics of heart failure patients with reduced or preserved ejection fraction.
    Huusko J; Purmonen T; Toppila I; Lassenius M; Ukkonen H
    ESC Heart Fail; 2020 Jun; 7(3):1039-1048. PubMed ID: 32187879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The prognostic value of free triiodothyronine/free thyroxine ratio in patients hospitalized with heart failure].
    Zhou P; Huang LY; Zhai M; Huang Y; Zhuang XF; Liu HH; Zhang YH; Zhang J
    Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(22):1679-1684. PubMed ID: 37302858
    [No Abstract]   [Full Text] [Related]  

  • 9. High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network.
    Fudim M; Ambrosy AP; Sun JL; Anstrom KJ; Bart BA; Butler J; AbouEzzeddine O; Greene SJ; Mentz RJ; Redfield MM; Reddy YNV; Vaduganathan M; Braunwald E; Hernandez AF; Borlaug BA; Felker GM
    J Am Heart Assoc; 2018 Dec; 7(24):e010364. PubMed ID: 30561266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher Peripheral Thyroid Sensitivity Is Linked to a Lower Risk of Heart Failure After Acute Myocardial Infarction.
    Lang X; Zhao B; Fang S; Li L; Li Z; Wu N; Zhang Y; Xing L; Li Y; Zhang Y
    J Clin Endocrinol Metab; 2023 Oct; 108(11):2950-2960. PubMed ID: 37104944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Affecting Biochemical and Echocardiographic Indices in Type 2 Diabetes Mellitus Patients Without Overt Symptoms of Heart Failure: A Cross-Sectional Study.
    Singh RK; Singh KK; Singh A; Khan IA; Yadav SC
    Cureus; 2023 Oct; 15(10):e46904. PubMed ID: 37954809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Low-Normal Free Triiodothyronine Level Is Associated with Adverse Prognosis in Euthyroid Patients with Heart Failure Receiving Cardiac Resynchronization Therapy.
    Chen YY; Shu XR; Su ZZ; Lin RJ; Zhang HF; Yuan WL; Wang JF; Xie SL
    Int Heart J; 2017 Dec; 58(6):908-914. PubMed ID: 29151481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T.
    Emdin M; Aimo A; Vergaro G; Bayes-Genis A; Lupón J; Latini R; Meessen J; Anand IS; Cohn JN; Gravning J; Gullestad L; Broch K; Ueland T; Nymo SH; Brunner-La Rocca HP; de Boer RA; Gaggin HK; Ripoli A; Passino C; Januzzi JL
    J Am Coll Cardiol; 2018 Nov; 72(19):2309-2320. PubMed ID: 30384887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Troponin I and Risk of Cardiac Events in Patients With Heart Failure and Preserved Ejection Fraction.
    Myhre PL; O'Meara E; Claggett BL; de Denus S; Jarolim P; Anand IS; Beldhuis IE; Fleg JL; Lewis E; Pitt B; Rouleau JL; Solomon SD; Pfeffer MA; Desai AS
    Circ Heart Fail; 2018 Nov; 11(11):e005312. PubMed ID: 30571192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Biomarkers and Risk of Incident Heart Failure in Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Bansal N; Zelnick L; Go A; Anderson A; Christenson R; Deo R; Defilippi C; Lash J; He J; Ky B; Seliger S; Soliman E; Shlipak M; ;
    J Am Heart Assoc; 2019 Nov; 8(21):e012336. PubMed ID: 31645163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction.
    Cunningham JW; Vaduganathan M; Claggett BL; Zile MR; Anand IS; Packer M; Zannad F; Lam CSP; Janssens S; Jhund PS; Kober L; Rouleau J; Shah SJ; Chopra VK; Shi VC; Lefkowitz MP; Prescott MF; Pfeffer MA; McMurray JJV; Solomon SD
    JACC Heart Fail; 2020 May; 8(5):372-381. PubMed ID: 32241619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction.
    Liu D; Hu K; Schregelmann L; Hammel C; Lengenfelder BD; Ertl G; Frantz S; Nordbeck P
    ESC Heart Fail; 2023 Apr; 10(2):1358-1371. PubMed ID: 36732921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NT-proBNP is a potential mediator between reduced ejection fraction and depression in patients with heart failure.
    Zuzarte P; Scola G; Duong A; Kostiw K; Figueira ML; Costa-Vitali A
    J Psychiatr Res; 2018 Sep; 104():8-15. PubMed ID: 29913350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.
    Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y
    Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid hormone is associated with heart failure with preserved ejection fraction.
    Bezgin T; Elveran A; Karagoz A; Canga Y; Dogan C
    Bratisl Lek Listy; 2016; 117(8):442-7. PubMed ID: 27546695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.